Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Genetics Investing
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China Pharmaceutical Investing
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies Genetics Investing
Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma Pharmaceutical Investing
Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne Genetics Investing
Asterias Biotherapeutics Reports Fourth Quarter and Full Year 2017 Financial Results Biotech Investing